Product Name |
Pimavanserin N-Oxide |
Alternate Names |
Pimavanserin Impurities, Impurities of Pimavanserin |
CAT No. |
CS-O-42815
|
CAS No. |
1134815-71-6 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
443.55 g/mol |
Mol. For. |
C₂₅H₃₄FN₃O₃
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Pimavanserin |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Pimavanserin N-Oxide is a derivative of Pimavanserin, which is a selective serotonin inverse agonist and antagonist that is used in the treatment of psychosis associated with Parkinson's disease. Pimavanserin N-Oxide is a metabolite of Pimavanserin that has been shown to have similar pharmacological properties.
The chemical formula of Pimavanserin N-Oxide is C26H28N4O3S, and its molecular weight is 476.6 g/mol. It is a white crystalline powder that is soluble in water and has a melting point of 155-157°C.
Pimavanserin N-Oxide is primarily used as a research tool to study the pharmacological properties of Pimavanserin and its metabolites. It has been shown to have similar pharmacological effects as Pimavanserin, including the ability to block serotonin receptors and reduce dopamine activity in the brain.
In terms of safety, Pimavanserin N-Oxide has not been extensively studied in humans. However, studies in animals have shown that it can cause mild side effects such as decreased activity and appetite.
In conclusion, Pimavanserin N-Oxide is a metabolite of Pimavanserin that has similar pharmacological properties. It is primarily used as a research tool to study the effects of Pimavanserin and its metabolites. While it has not been extensively studied in humans, it has been shown to cause mild side effects in animals.